Q2: 2026-05-06 Earnings Summary
EPS of $4.75 beats by $0.02
| Revenue of $78.36B (3.85% Y/Y) misses by $2.68B
Cencora, Inc. (COR) Bank of America Global Healthcare Conference 2026 May 13, 2026 11:00 AM EDT
Company Participants
Robert Mauch – President, CEO & Director
James Cleary – Executive VP & CFO
Bennett Murphy – Senior VP Of Investor Relations & Enterprise Productivity and Treasury
Conference Call Participants
Allen Lutz – BofA Securities, Research Division
Presentation
Allen Lutz
BofA Securities, Research Division
All right. Good morning. Welcome to day 2 of the BofA Global Healthcare Conference. My name is Allen Lutz, I run health care tech and distribution here at Bank of America. We are excited to have the Cencora team here. We have President and CEO, Bob Mauch; EVP and CFO, Jim Cleary; and Head of Investor Relations and Enterprise Productivity, Bennett Murphy. Thank you to the team for joining us. Really appreciate it.
Question-and-Answer Session
Allen Lutz
BofA Securities, Research Division
I’ll start with Bob. You reported earnings last week. I guess before we dive in, is there anything you want to highlight about the quarter or just any thoughts there?
Robert Mauch
President, CEO & Director
Yes. First, thanks, Allen. Thanks for having us. We’re excited to be here to talk about Cencora. And I’ll say we don’t take the recent pullback in our shares lightly, and we wanted to be here to explicitly express our confidence in our full year guidance as well as our long-term guidance. We recognize that there are some noise around the quarter and so we want to do everything that we can to make sure everybody understands why we have that confidence.
And I’ll also note that in our press release, we announced that we were resuming share repurchases and that we expect to repurchase $1 billion in shares by the end of the calendar year. Maybe most importantly, longer term is why we’re confident and
